Repaglinide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 904 publications
The Impact of Polymers in Amorphous Solid Dispersion on the Bioavailability of Sulfonylureas and Meglitinides.
Journal: Drug design, development and therapy
Published: March 19, 2026
Helicobacter pylori Eradication Therapy-induced Severe Hypoglycemia in a Hemodialysis Patient with Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
Repaglinide Provokes Dose-Dependent Myocardial Toxicity via Disrupting HIF-1α, TLR4/MyD88, and NF-κB Pathway: A Biochemical, Radiological, and Histological Approach.
Journal: Journal of applied toxicology : JAT
Published: March 01, 2026
Pharmacokinetic and Bioequivalence Evaluation of Two Repaglinide Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.
Journal: Clinical pharmacology in drug development
Published: January 06, 2026
Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis.
Journal: The AAPS journal
Published: December 02, 2025
Noninsulin drugs for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025
Corrigendum to "Human cytochrome P4502C8 metabolizes repaglinide to 4'-hydroxyrepaglinide, not 3'-hydroxyrepaglinide" [Drug Metabolism and Disposition 53 (2025) 100177].
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: November 13, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamics of zapnometinib: results from a phase I clinical study.
Journal: Frontiers in pharmacology
Published: November 10, 2025
LC-MS/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats.
Journal: Analytical methods : advancing methods and applications
Published: October 31, 2025
Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064.
Journal: Biomedicines
Published: October 03, 2025
Collecting Metabolite Pharmacokinetics in Drug-Drug Interaction Studies: A Review of Industry Practices and Data Utilization.
Journal: Clinical pharmacokinetics
Published: October 02, 2025
Last Updated: 06/30/2026